Leadership & Pay ·
Mirum Pharmaceuticals announced that Rob Myers, M.D., will succeed Joanne Quan, M.D., as Chief Medical Officer
MIRMMirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals announced that Rob Myers, M.D., will succeed Joanne Quan, M.D., as Chief Medical Officer. Dr. Quan ceased serving in this role on September 2, 2026, with her employment termination expected on October 19, 2026. The separation is treated as involuntary under the company's Severance Plan, entitling Dr. Quan to standard benefits and an extension of her stock option exercise period to 12 months post-separation. Additionally, her 2026 annual target bonus will be paid at the 100% achievement level upon separation. Dr. Myers is expected to begin employment on September 21, 2026. Mirum Pharmaceuticals operates in the biopharmaceutical industry, focusing on the development of treatments for liver diseases.